Vascular endothelial growth factor induction of the angiogenic phenotype requires Ras activation.

被引:226
作者
Meadows, KN [1 ]
Bryant, P [1 ]
Pumiglia, K [1 ]
机构
[1] Albany Med Coll, Ctr Cell Biol & Canc Res, Albany, NY 12208 USA
关键词
D O I
10.1074/jbc.M108069200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We investigated the role of Ras in vascular endothelial growth factor (VEGF)-mediated signal transduction and the promotion of angiogenic changes primary endothelial cells. We find that VEGF potently induces Ras activation and that this step is essential for the stimulation by VEGF of several cellular changes associated with angiogenesis, including proliferation, migration, and branching morphogenesis in three-dimensional culture. Inhibition of Ras signaling induced subtle changes in the actin architecture but had no effect on the phosphatidylinositol 3-kinase (PI3K) or p38 signaling pathways. In contrast, activation of ERK was largely dependent on Ras. Although inhibiting ERK activity completely suppressed cell proliferation and partially blocked in vitro differentiation, neither ERK nor PI3K activity was required for VEGF-induced migration. These data provide the first direct demonstration that inhibition of Ras signal transduction is anti-angiogenic. Interestingly, VEGF signal transduction bifurcates both upstream and downstream of Ras, with different Has-dependent signals controlling endothelial cell proliferation and migration, essential components of the angiogenic response.
引用
收藏
页码:49289 / 49298
页数:10
相关论文
共 55 条
  • [1] Oncogenic H-ras stimulates tumor angiogenesis by two distinct pathways
    Arbiser, JL
    Moses, MA
    Fernandez, CA
    Ghiso, N
    Cao, YH
    Klauber, N
    Frank, D
    Brownlee, M
    Flynn, E
    Parangi, S
    Byers, HR
    Folkman, J
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (03) : 861 - 866
  • [2] Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele
    Carmeliet, P
    Ferreira, V
    Breier, G
    Pollefeyt, S
    Kieckens, L
    Gertsenstein, M
    Fahrig, M
    Vandenhoeck, A
    Harpal, K
    Eberhardt, C
    Declercq, C
    Pawling, J
    Moons, L
    Collen, D
    Risau, W
    Nagy, A
    [J]. NATURE, 1996, 380 (6573) : 435 - 439
  • [3] Angiogenesis in cancer and other diseases
    Carmeliet, P
    Jain, RK
    [J]. NATURE, 2000, 407 (6801) : 249 - 257
  • [4] Minimal Ras-binding domain of Raf1 can be used as an activation-specific probe for Ras
    deRooij, J
    Bos, JL
    [J]. ONCOGENE, 1997, 14 (05) : 623 - 625
  • [5] THE FMS-LIKE TYROSINE KINASE, A RECEPTOR FOR VASCULAR ENDOTHELIAL GROWTH-FACTOR
    DEVRIES, C
    ESCOBEDO, JA
    UENO, H
    HOUCK, K
    FERRARA, N
    WILLIAMS, LT
    [J]. SCIENCE, 1992, 255 (5047) : 989 - 991
  • [6] VEGF stimulates MAPK through a pathway that is unique for receptor tyrosine kinases
    Doanes, AM
    Hegland, DD
    Sethi, R
    Kovesdi, I
    Bruder, JT
    Finkel, T
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1999, 255 (02) : 545 - 548
  • [7] BIOLOGICAL-ACTIVITY AND PHOSPHORYLATION SITES OF THE BACTERIALLY EXPRESSED CYTOSOLIC DOMAIN OF THE KDR VEGF-RECEPTOR
    DOUGHERVERMAZEN, M
    HULMES, JD
    BOHLEN, P
    TERMAN, BI
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1994, 205 (01) : 728 - 738
  • [8] A SYNTHETIC INHIBITOR OF THE MITOGEN-ACTIVATED PROTEIN-KINASE CASCADE
    DUDLEY, DT
    PANG, L
    DECKER, SJ
    BRIDGES, AJ
    SALTIEL, AR
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (17) : 7686 - 7689
  • [9] DVORAK HF, 1995, AM J PATHOL, V146, P1029
  • [10] ELGJO RF, 1975, CELL TISSUE RES, V162, P49